BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9646853)

  • 1. Expression of HER-2/neu oncogene in normal, hyperplastic, and malignant endometrium.
    Rasty G; Murray R; Lu L; Kubilis P; Benrubi G; Masood S
    Ann Clin Lab Sci; 1998; 28(3):138-43. PubMed ID: 9646853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of HER-2/neu, epidermal growth factor receptor, and steroid receptor expression in normal and malignant endometrium.
    Bigsby RM; Li AX; Bomalaski J; Stehman FB; Look KY; Sutton GP
    Obstet Gynecol; 1992 Jan; 79(1):95-100. PubMed ID: 1345772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of HER-2/neu oncogene amplification by fluorescence in situ hybridization in stage I endometrial carcinoma.
    Riben MW; Malfetano JH; Nazeer T; Muraca PJ; Ambros RA; Ross JS
    Mod Pathol; 1997 Aug; 10(8):823-31. PubMed ID: 9267826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
    Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
    Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of immunohistochemically detected HER-2/neu oncoprotein in endometrial cancer.
    Kohlberger P; Loesch A; Koelbl H; Breitenecker G; Kainz C; Gitsch G
    Cancer Lett; 1996 Jan; 98(2):151-5. PubMed ID: 8556702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of HER-2/neu oncogene in cervical cancer.
    Ndubisi B; Sanz S; Lu L; Podczaski E; Benrubi G; Masood S
    Ann Clin Lab Sci; 1997; 27(6):396-401. PubMed ID: 9433536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukaemia inhibitory factor (LIF) is immunohistochemically expressed in normal, hyperplastic and malignant endometrial tissue.
    Mylonas I; Makovitzky J; Shabani N; Richter DU; Kuhn C; Jeschke U; Briese V; Friese K
    Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):101-8. PubMed ID: 15596282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma.
    Khan AJ; King BL; Smith BD; Smith GL; DiGiovanna MP; Carter D; Haffty BG
    Clin Cancer Res; 2002 Feb; 8(2):540-8. PubMed ID: 11839675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
    Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.
    Afify AM; Craig S; Paulino AF; Stern R
    Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification of c-erbB2 oncogene: a major prognostic indicator in uterine serous papillary carcinoma.
    Santin AD; Bellone S; Van Stedum S; Bushen W; Palmieri M; Siegel ER; De Las Casas LE; Roman JJ; Burnett A; Pecorelli S
    Cancer; 2005 Oct; 104(7):1391-7. PubMed ID: 16116605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer.
    Woo MM; Alkushi A; Verhage HG; Magliocco AM; Leung PC; Gilks CB; Auersperg N
    Clin Cancer Res; 2004 Dec; 10(23):7958-64. PubMed ID: 15585630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
    Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
    Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma.
    Vaskivuo TE; Stenbäck F; Tapanainen JS
    Cancer; 2002 Oct; 95(7):1463-71. PubMed ID: 12237915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia.
    Wang BY; Kalir T; Sabo E; Sherman DE; Cohen C; Burstein DE
    Cancer; 2000 Jun; 88(12):2774-81. PubMed ID: 10870060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic analysis of HER-2/neu immunoexpression among various histologic subtypes and grades of osteosarcoma.
    Kilpatrick SE; Geisinger KR; King TS; Sciarrotta J; Ward WG; Gold SH; Bos GD
    Mod Pathol; 2001 Dec; 14(12):1277-83. PubMed ID: 11743051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables.
    Ozuysal S; Oztürk H; Bilgin T; Filiz G
    Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence in situ hybridization analysis of HER-2/neu, c-myc, and p53 in endometrial cancer.
    Williams JA; Wang ZR; Parrish RS; Hazlett LJ; Smith ST; Young SR
    Exp Mol Pathol; 1999 Dec; 67(3):135-43. PubMed ID: 10600396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
    Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
    Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.